CRISPR Technology: Global Markets
Report ScopeThis report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.
Report Includes32 data tables and 61 additional tables
An analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
Analyses of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
Discussion of the market potential for CRISPR technology
Estimate of the market size and a revenue forecast for the global CRISPR technology market, and a corresponding market share analysis by application, end user, and region
Discussion of the major market dynamics, regulations, industry challenges, and macroeconomic factors that will affect the demand for CRISPR technology market over the next five years
A look at the recent breakthrough in CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
A comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
A discussion on ESG challenges and ESG practices of the industry participants
A look at the proprietary technologies and strategic alliances of the companies best positioned in the CRISPR market
Analysis of the industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19
Company profiles of the major players, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics and Danaher Corp.
Companies MentionedAGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
DANAHER CORP.
EDITAS MEDICINE
GENSCRIPT
INTELLIA THERAPEUTICS INC.
LONZA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.